bf/NASDAQ:XLO_icon.jpeg

NASDAQ:XLO

Xilio Therapeutics, Inc.

  • Stock

USD

Last Close

0.96

26/07 20:00

Market Cap

35.44M

Beta: -

Volume Today

88.76K

Avg: 29.09K

PE Ratio

−0.23

PFCF: −0.25

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
asset turnover
cash per share
1.83
-
0.72
60.61%
35.33
4,796.69%
4.39
87.56%
1.63
63.01%
company equity multiplier
-2.12
-
-0.44
79.48%
1.18
369.69%
1.32
12.01%
1.65
25.59%
days of inventory outstanding
days of payables outstanding
days of sales outstanding
dividend yield
ebit per revenue
ebt per ebit
0.91
-
1.01
11.23%
1.01
0.19%
0.99
2.03%
effective tax rate
0.02
-
0.01
46.87%
enterprise value multiple
-21.10
-
-8.01
62.03%
1.17
114.61%
0.30
74.35%
0.26
14.16%
fixed asset turnover
free cash flow per share
-0.70
-
-1.44
106.27%
-14.60
917.06%
-2.83
80.60%
-2.51
11.27%
gross profit margin
interest coverage
96.17
-
inventory turnover
long term debt to capitalization
-1.71
-
-0.28
83.51%
0.10
134.11%
0.10
8.84%
0.18
72.94%
net income per ebt
1
-
1
0%
0.98
1.98%
0.99
0.95%
net profit margin
operating cash flow per share
-0.67
-
-1.35
102.27%
-14.40
964.22%
-2.76
80.81%
-2.50
9.72%
operating profit margin
payables turnover
pretax profit margin
price fair value
-14.45
-
-5.12
64.55%
0.48
109.44%
0.70
44.18%
0.41
41.12%
receivables turnover
return on assets
-0.28
-
-1.52
450.90%
-0.34
77.59%
-0.63
84.09%
return on capital employed
-0.33
-
-3.85
1,064.62%
-0.37
90.51%
-0.76
106.59%
-1.76
133.01%
return on equity
0.59
-
0.66
13.07%
-0.40
160.44%
-0.83
106.21%
total debt to capitalization
-1.71
-
-0.34
80.02%
0.10
129.17%
0.16
59.24%
0.20
25.78%

All numbers in USD (except ratios and percentages)